Tenaya (TNYA) CEO Ali Faraz Sells Shares

What Happened
Ali Faraz, CEO of Tenaya Therapeutics (TNYA), sold a total of 22,232 shares in open-market transactions on August 17, 2026. The sales were reported as disposals (code S) at a weighted average price of $0.71 per share, netting approximately $15,779. According to the filing, these sales were made to cover tax withholding obligations tied to the vesting of restricted stock units (RSUs) and are routine (not purchases).

Key Details

• Transaction date: 2026-08-17 (all sales reported the same day).
• Shares sold: 5,837; 3,969; 5,020; and 7,406 — total 22,232 shares.
• Price: weighted average $0.71; individual sale prices ranged from $0.6820 to $0.7253 (filing offers to provide per-price breakdown on request).
• Total proceeds: ~$15,779.
• Reason: Shares sold to cover tax withholding on vested RSUs (footnotes cite RSU awards dated Feb 15, 2023; Feb 23, 2024; Feb 6, 2025; Feb 3, 2026). Transaction code for withholding = F.
• Holdings note: The filing’s footnotes indicate the reporting person’s beneficial ownership includes unvested RSUs totaling 1,145,250 shares (305,956 + 295,331 + 281,894 + 262,069). The provided data did not list a separate aggregate “shares owned after transaction” figure.
• Timeliness: Filing date and period of report are both 2026-08-17 — the report appears filed promptly.

Context
These sales were tax-withholding dispositions tied to RSU vesting (cashless-style sell to cover taxes), which are routine and do not by themselves indicate the insider’s view on the company’s prospects. For retail investors, purchases or new grants are generally more informative about insider conviction than routine withholding sales.